We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Novo Nordisk has signed a collaboration and exclusive option agreement with Dutch drug maker Staten Biotechnology for the development of new therapies to treat hypertriglyceridaemia......